TherapeuticsMD logo
TherapeuticsMD TXMD
$ 1.36 2.26%

Quarterly report 2024-Q2
added 08-12-2024

report update icon

TherapeuticsMD Financial Statements 2011-2024 | TXMD

Annual Financial Statements TherapeuticsMD

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

23.9 M 32.1 M 119 M 450 M 584 M 1.15 B 1.27 B 1.11 B 1.24 B 608 M 860 M 294 M 128 M

Shares

10.4 M 9.03 M 7.96 M 273 M 246 M 225 M 206 M 196 M 173 M 150 M 128 M 91.6 M 62.5 M

Historical Prices

2.29 3.56 15 82.5 112 262 294 290 358 203 329 160 100

Net Income

-10.3 M 112 M -172 M -184 M -176 M -133 M -76.9 M -89.9 M -85.1 M -54.2 M -28.4 M -35.1 M -12.9 M

Revenue

1.3 M 70 M 2.57 M 64.9 M 49.6 M 16.1 M 16.8 M 19.4 M 20.1 M 15 M 8.78 M 3.82 M 2.09 M

Cost of Revenue

- 1.4 M 1.4 M 16 M 6.34 M 2.74 M 2.64 M 4.19 M - - - - -

Gross Profit

1.3 M 68.6 M 1.17 M 48.9 M 43.3 M 13.4 M 14.1 M 15.2 M 15.6 M 11.4 M 6.82 M 2.47 M 1.14 M

Operating Income

-8.52 M 1.19 M -79.6 M -156 M -151 M -130 M -77.6 M -90.3 M -85.2 M -54 M -25.8 M -16.1 M -5.43 M

Interest Expense

300 K 200 K 32.9 M 28.6 M 17.4 M 4.68 M - - - 1.17 M 1.91 M 1.91 M 64.4 K

EBITDA

-7.6 M 2.38 M -78.8 M -154 M -151 M -130 M -77.4 M -90.1 M -85.1 M -54 M -25.8 M -16.1 M -5.37 M

Operating Expenses

9.82 M 67.4 M 80.7 M 204 M 195 M 144 M 91.8 M 105 M 101 M 65.4 M 32.6 M 18.6 M 6.57 M

General and Administrative Expenses

8.9 M 56.7 M 80.7 M 193 M - - - - - - - - -

All numbers in USD currency

Quarterly Income Statement TherapeuticsMD

2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

11.5 M 11.5 M 10.7 M 10.2 M 9.75 M 9.5 M 9.26 M 8.75 M 8.61 M 8.6 M 8.44 M 7.88 M 6.94 M 300 M 273 M 272 M 271 M 271 M 241 M 241 M 241 M 240 M 228 M 217 M 217 M 216 M 208 M 203 M 198 M 197 M 197 M 196 M 195 M 178 M 177 M 173 M 163 M 156 M 152 M 145 M 145 M 145 M 131 M 131 M 103 M 99.8 M 95.9 M 86.1 M 84.6 M 83 M 58.4 M 57.5 M 55.7 M

Net Income

-1.09 M - -3.38 M -2.41 M -3.6 M - -29 M 112 M -49 M -43 M -47.4 M -42.7 M -39.4 M -42.1 M -32.6 M -52 M -56.8 M -49.4 M -32 M -55.2 M -39.5 M -39.4 M -35.6 M -33.2 M -24.4 M -21.4 M -14.7 M -19.7 M -21.2 M -22.8 M -25 M -21.1 M -20.9 M -17.5 M -19.5 M -27.2 M -20.9 M -16.3 M -17.8 M -10.9 M -9.18 M -8.36 K -7.67 K -6.01 K -6.38 K -5.73 K -4.25 K -11.8 K -13.3 K - -1.49 M -1.07 M -774 K

Revenue

- - -53 K 437 K 416 K - 354 K 348 K 695 K 18.7 M 25.4 M 23 M 19.9 M 22.6 M 19.3 M 10.7 M 12.3 M 15.9 M 23.7 M 6.08 M 3.95 M 5.09 M 3.47 M 3.76 M 3.77 M 4.12 M 4.42 M 4.25 M 3.99 M 4.49 M 5.54 M 4.4 M 4.93 M 5.63 M 5.19 M 4.85 M 4.48 M 4.26 M 4.19 M 3.75 M 2.83 M 2.86 K 2.29 M 2.08 M 1.54 M 1.24 K 1.04 M 819 K 722 K - 540 K 508 K 486 K

Cost of Revenue

- - - - - - 354 K 348 K 695 K - 5.28 M 4.13 M 4.69 M - 3.28 M 4.4 M 2.72 M - 1.44 M 1.25 M 763 K - 699 K 454 K 634 K - 701 K 682 K - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - -53 K 437 K 416 K - 17.1 M 23.8 M 14.5 M 13.9 M 20.1 M 18.9 M 15.2 M 17 M 16.1 M 6.3 M 9.54 M 13 M 22.3 M 4.83 M 3.18 M 4.14 M 2.78 M 3.31 M 3.14 M 3.53 M 3.72 M 3.57 M 3.33 M 3.78 M 4.3 M 3.27 M 3.82 M 4.4 M 4 M 3.82 M 3.43 M 3.38 M 3.12 M 2.86 M 2 M 2.4 K 1.65 K 1.62 K 1.16 K 908 729 447 386 - 298 K 269 K 282 K

Operating Income

-2.44 M - -1.77 M -2.47 M -2.67 M - -14.5 M -14.9 M -17.9 M -35.4 M -39.9 M -35.2 M -29.3 M -34.6 M -25 M -45 M -50.9 M - -27.1 M -41.6 M -38.1 M - -34.4 M -33 M -24.7 M - -14.8 M -19.8 M -21.3 M - -25.1 M -21.2 M -21 M - -19.5 M -27.3 M -20.9 M - -17.8 M -10.9 M -8.95 M - -7.24 M -5.62 M -4.94 M - -3.91 M -3.97 M -2.87 M - -1.44 M -1.05 M -771 K

Interest Expense

- - 20 K 45 K 50 K - 4.83 M 11.7 M 14.4 M - 7.52 M 7.6 M 10.2 M - 7.68 M 7.03 M 6.26 M - 5.6 M 4.03 M 2.09 M - 2.05 M 531 K - - - - - - - - - - - - - - - - - - - 150 1.17 M - 134 K 1.15 M 102 K - 16.5 K 232 -

EBITDA

-2.26 M - - -2.34 M -2.64 M - -14.3 M -14.7 M -17.5 M -35.4 M -36.8 M -33.1 M -28.3 M -34.6 M -24.7 M -44.8 M -49.9 M - -26.9 M -41.5 M -38 M - -34.3 M -33 M -24.7 M - -14.8 M -19.8 M -21.2 M - -25.1 M -21.2 M -21 M - -19.5 M -27.2 M -20.9 M - -17.8 M -10.9 M -8.94 M - -7.2 M -5.61 M -4.93 M 28.8 K -3.9 M -3.96 M -2.85 M - -1.4 M -1.02 M -758 K

Operating Expenses

2.67 M - 1.72 M 2.91 M 3.08 M - 14.5 M 14.9 M 17.9 M - 60 M 54 M 44.5 M - 41 M 51.3 M 60.5 M - 49.3 M 46.5 M 41.3 M - 37.1 M 36.3 M 27.9 M - 18.5 M 23.4 M 24.6 M - 29.4 M 24.5 M 24.8 M - 23.5 M 31.1 M 24.4 M - 21 M 13.8 M 11 M - 8.88 M 7.23 M 6.1 M - 4.64 M 4.42 M 3.25 M - 1.74 M 1.32 M 1.05 M

General and Administrative Expenses

1.23 M - 1.59 M 2.78 M 3.06 M - 14.2 M 14.6 M 17.5 M - 28.4 M 19.9 M 18.4 M - 16.6 M 18.7 M 57.2 M - 45.1 M 41.4 M 34.9 M - 30.4 M 29.5 M 20.8 M - 12.1 M 14.6 M 16.8 M - 14.7 M 10.6 M 9.68 M - 7.06 M 6.87 M 6.16 M - 6.04 M 5.54 M 5.03 M - 4.75 M 5.48 M 4.53 M - 2.92 M 3.57 M 2.83 M - 64.6 K 58.6 K 985 K

All numbers in USD currency